Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-23

Clinical Trial Update: Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Cellcept for Juvenile Neuronal Ceroid Lipofuscinosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: University of Rochester | Conditions: Juvenile Neuronal Ceroid Lipofuscinosis | Phase 2 | Status: COMPLETED | Results posted: 2017-01-23